scorecardresearch
Add as a preferred source on Google
Friday, December 19, 2025
TopicCovishield

Topic: Covishield

Ghana President Akufo-Addo slams European nations for not recognising India-made Covishield

At the 76th UN General Assembly session Wednesday, President Nana Addo Dankwa Akufo-Addo said use of vaccines as a 'tool for immigration control will be a truly retrogressive step'.

Rajeev Chandrasekhar contradicts govt on UK vaccine row, says nations doing what’s best for them

MoS Rajeev Chandrasekhar says he is not speaking on behalf of Modi govt but notes UK govt decision is simply a case of country doing what's in its best interest.

UK has issue with India’s CoWin certification, not vaccine. Travel restrictions to remain

Travelling from India to UK is not going to get easier from 4 Oct, despite most Indians receiving Oxford-AstraZeneca vaccine. Jaishankar meets counterpart, asks for resolution.

UK travel restriction issue is more about technologies and processes than Covid vaccine

ThePrint view on the most important issues, instantly.

How Sri Lanka is facing an economic disaster after overnight switch to total organic farming

A selection of the best news reports, analysis and opinions published by ThePrint this week.

Centre places order with Serum Institute of India for 66 crore Covishield doses

SII has enhanced the manufacturing capacity of Covishield to more than 20 crore doses per month, and the latest consignment ordered by Centre is to be supplied by December.

Single vaccine shot 96.6%, 2 doses 97.5% effective in preventing Covid deaths, ICMR finds

ICMR analysis, based on outcome of all vaccines administered in India till 15 August, is important because India has among the longest gaps between Covishield doses.

In India’s vaccination race, Covishield at 88% beats Covaxin hands down

Govt data shows that 65.28 crore doses have been administered. Of this, Covaxin accounts for just 12.1% of doses administered.

Over 11-month gap between Covishield shots gives better antibody levels: Oxford study in Lancet

The Lancet study suggests an increased gap between Covishield doses could be good news, adds that booster shot can be taken about 9 months after both doses.

At 16.4 cr doses, SII’s increased Covishield output helps India cross Aug vaccination target

Modi govt, which projected 15 crore doses would be available in August, managed to achieve its 1 crore-doses-a-day plan last week. Meanwhile, Covaxin production lags.

On Camera

Bondi Beach attack holds lessons for India too — soft targets remain terror’s first choice

India’s counter-terror focus must go beyond organised modules to include individual radicalisation, mental health-linked violence, and spontaneous attacks in public spaces.

Antitrust watchdog Competition Commission to probe IndiGo flight disruptions

While the commission didn’t mention provisions under which IndiGo's market domination would be examined, Competition Act 2002 prohibits abuse of dominant position by any enterprise.

Israel has ‘realised who its real friend is’, eyes defence expansion in India amid arms curbs by others

It is argued that India-Israel ties are moving from buyer–seller dynamic to one focused on joint development & manufacturing partnership, a shift 'more durable' than traditional arms sales.

India’s top airline just handed sarkar the keys. That’s IndiGo’s real ‘crime’

Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.